Anika Therapeutics, Inc. (ANIK) Balance Sheet
As of 2026-06-30 (10-Q), Anika Therapeutics, Inc. (ANIK) reported total assets of $183.5M and shareholders' equity of $137.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $38.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ANIKAnika Therapeutics, Inc.Follow ANIK — free
—
Price chart with a free account
- Market cap
- 286.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 35.8 | 44.1 | 63.3 | 100.2 | 110.7 | 104.3 | 133.3 | 89.0 | 157.5 | 95.8 | 94.4 | 86.3 | 68.7 | 55.6 | 57.5 | 38.4 | |
| Short-term investments | — | — | — | 6.8 | 27.8 | 20.5 | 24.0 | 70.0 | 27.5 | 2.5 | 29.8 | 34.6 | 26.4 | 23.6 | 23.7 | — | |
| Receivables | 17.3 | 21.5 | 18.7 | 17.2 | 21.7 | 27.6 | 23.8 | 20.8 | 23.1 | 24.1 | 29.8 | 34.6 | 26.4 | 23.6 | 23.7 | 29.1 | |
| Inventory | 7.3 | 8.3 | 11.0 | 12.4 | 14.9 | 16.0 | 22.0 | 21.3 | 22.0 | 46.2 | 36.0 | 39.8 | 24.4 | 23.8 | 18.8 | 28.6 | |
| Current assets | 64.1 | 77.4 | 94.6 | 137.8 | 176.4 | 170.4 | 206.3 | 202.9 | 234.3 | 177.4 | 168.5 | 169.5 | 163.3 | 113.7 | 103.4 | 99.2 | |
| Total assets | 132.8 | 142.1 | 156.0 | 192.8 | 235.7 | 240.2 | 282.6 | 279.0 | 330.7 | 365.6 | 347.5 | 349.1 | 270.6 | 202.7 | 190.3 | 183.5 | |
| Current liabilities | 14.5 | 14.5 | 9.3 | 6.0 | 17.3 | 8.8 | 13.1 | 11.3 | 16.3 | 36.9 | 29.8 | 27.9 | 31.1 | 23.3 | 21.9 | 22.1 | |
| Long-term debt | 9.6 | 8.0 | — | — | — | — | — | — | 0.0 | — | — | — | — | — | — | — | |
| Short-term debt | 1.6 | 1.6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Shareholders' equity | 94.8 | 108.9 | 135.6 | 178.1 | 210.8 | 222.8 | 263.5 | 263.6 | 288.4 | 272.4 | 287.1 | 285.6 | 212.3 | 154.0 | 143.5 | 137.3 |
USD millions · SEC XBRL
Anika Therapeutics, Inc. — questions
- How much cash does Anika Therapeutics, Inc. have?
- $38.4M in cash and cash equivalents as of 2026-06-30.
- What are Anika Therapeutics, Inc.'s total assets?
- $183.5M as of 2026-06-30.
- What is Anika Therapeutics, Inc.'s shareholders' equity?
- $137.3M as of 2026-06-30.
Every figure on this page comes from Anika Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.